Skip to content

Effect of vaginal evening primrose capsules on ripening of the cervix

Effect of vaginal evening primrose capsules on ripening of the cervix of nulliparous pregnant women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181107041585N3
Enrollment
200
Registered
2020-04-07
Start date
2018-09-23
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post term pregnancy. Post-term pregnancy

Interventions

Intervention 1: Intervention group: Administration of single dose of 1000 mg evening primrose oil capsule made by Natural-weber Canada company vaginally immediately after admission and after primery e

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Nuliparity 18-35 years old BMI 18.5-24.9 Kg/m2 Singleton pregnancy Gestational age of 41 weeks according to valid menstrual period or reliable first trimester pregnancy Alive fetus Cephalic presentation Intact amniotic fluid sac Reassure base non stress test Bishop score less than 4 No regular uterine contractions

Exclusion criteria

Exclusion criteria: Abnormal fetal heart changes in labor Abnormal maternal vital signs in labor Mecounial amniotic fluid Abnormal vaginal bleeding in labor

Design outcomes

Primary

MeasureTime frame
Bishop score is the sum score of the place, dilation, effecment, position, and station of cervix to prognoses the ability of cervix for delivery. Timepoint: Before the administration of drugs and 6 hours after the administration of drug. Method of measurement: Bishop scoring scale.

Secondary

MeasureTime frame
Method of delivery. Timepoint: After delivery. Method of measurement: Patients record.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Darsareh

Bandare-abbas University of Medical Sciences

famadarsareh@yahoo.com+98 76 3367 0285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026